Duty Brian D, Wozniak Susan E, Selden Nathan R
Department of Urology, North Shore University Hospital Long Island Jewish Medical Center, Manhasset, New York, USA.
J Neurosurg Pediatr. 2011 Apr;7(4):413-5. doi: 10.3171/2011.1.PEDS10520.
Congenital central hypoventilation syndrome (CCHS) is a rare, idiopathic disorder characterized by a failure of automatic respiration. Abnormalities such as seizure disorder, failure to thrive, and Hirschsprung disease have been associated with CCHS. In this report, the authors discuss the use of vagal nerve stimulation (VNS) to treat a medically refractory seizure disorder in a child who had previously undergone placement of bilateral phrenic nerve stimulators for treatment of CCHS. Concomitant use of phrenic and vagal nerve stimulators has not previously been reported in the literature. No adverse reactions were noted with both devices working. Diaphragmatic pacing (DP) was clinically unaffected by VNS. The patient experienced a marked reduction in seizure frequency and severity following vagal nerve stimulator placement. Based on this case, the authors conclude that VNS is a potentially safe and efficacious treatment option for seizure disorder associated with CCHS in patients undergoing DP.
先天性中枢性低通气综合征(CCHS)是一种罕见的特发性疾病,其特征为自主呼吸功能衰竭。诸如癫痫症、生长发育迟缓及先天性巨结肠病等异常情况与CCHS有关。在本报告中,作者讨论了使用迷走神经刺激(VNS)来治疗一名儿童的药物难治性癫痫症,该儿童此前已接受双侧膈神经刺激器植入以治疗CCHS。膈神经和迷走神经刺激器联合使用此前在文献中尚无报道。两台设备同时运行时未发现不良反应。膈肌起搏(DP)在临床上未受VNS影响。在植入迷走神经刺激器后,患者癫痫发作的频率和严重程度显著降低。基于此病例,作者得出结论,对于正在接受DP治疗的CCHS相关癫痫症患者,VNS是一种潜在安全且有效的治疗选择。